Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease
Authors
Keywords
Alzheimer’s disease, Mild cognitive impairment, Brain-derived neurotrophic factor, Cerebrospinal fluid, Biomarkers, Pathophysiology
Journal
NEUROMOLECULAR MEDICINE
Volume 17, Issue 3, Pages 326-332
Publisher
Springer Nature
Online
2015-07-02
DOI
10.1007/s12017-015-8361-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression
- (2015) Willem Huijbers et al. BRAIN
- Increased plasma levels of BDNF and inflammatory markers in Alzheimer's disease
- (2014) Mayara Chaves Faria et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Reduced Cerebrospinal Fluid Levels of Brain-Derived Neurotrophic Factor Is Associated With Cognitive Impairment in Late-Life Major Depression
- (2014) B. S. Diniz et al. JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES
- Plasma biosignature and brain pathology related to persistent cognitive impairment in late-life depression
- (2014) B S Diniz et al. MOLECULAR PSYCHIATRY
- A Large, Cross-Sectional Observational Study of Serum BDNF, Cognitive Function, and Mild Cognitive Impairment in the Elderly
- (2014) Hiroyuki Shimada et al. Frontiers in Aging Neuroscience
- Anticipated Brain Molecular Aging in Major Depression
- (2013) Gaëlle Douillard-Guilloux et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Brain-derived neurotrophic factor levels in late-life depression and comorbid mild cognitive impairment: A longitudinal study
- (2013) Breno Satler Diniz et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Serum Brain-Derived Neurotrophic Factor and the Risk for Dementia
- (2013) Galit Weinstein et al. JAMA Neurology
- Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial
- (2011) Orestes V. Forlenza et al. BRITISH JOURNAL OF PSYCHIATRY
- Beneficial effects of a neurotrophic peptidergic mixture persist for a prolonged period following treatment interruption in a transgenic model of Alzheimer's disease
- (2011) Edward Rockenstein et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Brain-Derived Neurotrophic Factor and Alzheimer’s Disease: Physiopathology and Beyond
- (2011) Breno Satler Diniz et al. NEUROMOLECULAR MEDICINE
- Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: A preliminary 4-week study
- (2011) Rafael T. de Sousa et al. NEUROSCIENCE LETTERS
- Compensation and Disease Severity on the Memory-Related Activations in Mild Cognitive Impairment
- (2010) Francis Clément et al. BIOLOGICAL PSYCHIATRY
- Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function
- (2010) Antonio Lucio Teixeira et al. Biomarkers in Medicine
- Alzheimers Disease (AD) and Mild Cognitive Impairment (MCI) Patients are Characterized by Increased BDNF Serum Levels
- (2010) F. Angelucci et al. Current Alzheimer Research
- Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer’s disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin
- (2010) X. A. Alvarez et al. EUROPEAN JOURNAL OF NEUROLOGY
- Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment
- (2010) Orestes V. Forlenza et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression
- (2010) Breno Satler Diniz et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment
- (2010) Orestes Vicente Forlenza et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Development of a Non Invasive NGF-Based Therapy for Alzheimers Disease
- (2009) Sonia Covaceuszach et al. Current Alzheimer Research
- Association Study of the Decreased Serum BDNF Concentrations in Amnestic Mild Cognitive Impairment and the Val66Met Polymorphism in Chinese Han
- (2009) Hui Yu et al. JOURNAL OF CLINICAL PSYCHIATRY
- Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease
- (2009) Alan H Nagahara et al. NATURE MEDICINE
- Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor and Cognitive Function in Non-Demented Subjects
- (2009) Ge Li et al. PLoS One
- A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression
- (2008) André Russowsky Brunoni et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Aβ(1–42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT2A levels
- (2007) R. Christensen et al. EXPERIMENTAL NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search